Arkema's Stock Plummets by 2.95% Breaking Through Its Technical Support
Arkema's shares closed the trading session on Friday, October 10 at €49.74, marking a decline of 2.95% from the previous day's €51.25. This drop is part of a worsening trend that has accelerated over several weeks: the stock has now fallen 7.63% over seven days and 23.12% over three months. Over the year, the stock has lost 42.16%, a stark contrast to the CAC 40, which has gained 4.73% in the same period. Trading volumes accounted for 0.34% of the capital, reflecting moderate activity but enough to maintain selling pressure. The Paris index also ended lower by 1.53%, but Arkema's decline was significantly more pronounced.
Challenging Times for Arkema
This session comes in a difficult context for the group. On Wednesday, October 8, JP Morgan lowered its price target from €65 to €55 while maintaining a neutral recommendation, a revision that has impacted investor sentiment. This decision follows a warning issued by the company at the end of July, when it revised its annual forecasts downward, now expecting Ebitda between €1.3 and €1.4 billion, down from €1.532 billion in 2024, and current cash flow between €300 and €400 million, down from the initially hoped €600 million. Additionally, on Tuesday, October 7, the group announced the closure of two fluorinated gas production lines at its Pierre-Bénite site, a restructuring that could affect around fifty positions, heightening concerns about short-term business dynamics.
Technical Breakdown
Technically, the stock has broken below its support threshold at €51.20, a signal that indicates an intensification of selling pressure and paves the way for further declines. The Relative Strength Index (RSI) stands at 23, a level indicating a pronounced oversold condition and suggesting that the downward movement is reaching a rare intensity. This assessment is supported by the Chaikin Money Flow, which measures capital flows and is currently positioned at -0.20, showing a persistent outflow of liquidity and a dominant selling trend in recent volumes. The stock is also trading well below its 50-day and 200-day moving averages, at €58.35 and €66.72 respectively, confirming a negative long-term trend that has been established for several months. The Bollinger Bands, currently framing fluctuations between €50.45 and €59.85, indicate that the price is approaching the lower boundary, a configuration that could either signal an overselling excess or predict a continuation of the correction if this floor were to give way.
Market Impact and Outlook
The significant underperformance of Arkema compared to the broader market highlights the specific challenges faced by the company. The ongoing restructuring, coupled with downward revisions in financial forecasts and technical indicators suggesting continued bearish momentum, paints a cautious outlook for the stock. Investors and analysts will closely monitor the company's ability to navigate these turbulent times and any signs of stabilization or recovery in its stock price.
